Ani Pharmaceuticals Inc

UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC ANIP

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/13/2026

Shares

30,867

Value ($000)

2,437

Weight

0.0%

2019 Q4 - 2025 Q4 (22 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/13/2026	2,437	0.0%	30,867	12/31/2025
2025 Q3	11/14/2025	2,717	0.0%	29,666	9/30/2025
2025 Q2	8/14/2025	3,629	0.0%	55,624	6/30/2025
2025 Q1	5/19/2025	3,235	0.0%	48,322	3/31/2025
2024 Q4	2/14/2025	2,648	0.0%	47,899	12/31/2024
2024 Q3	11/14/2024	2,026	0.0%	33,951	9/30/2024
2024 Q2	8/14/2024	2,736	0.0%	42,971	6/30/2024
2024 Q1	5/15/2024	1,074	0.0%	15,536	3/31/2024
2023 Q4	2/14/2024	857	0.0%	15,536	12/31/2023
2023 Q3	11/13/2023	902	0.0%	15,536	9/30/2023
2023 Q2	8/11/2023	403	0.0%	10,153	6/30/2023
2023 Q1	5/15/2023	403	0.0%	10,153	3/31/2023
2022 Q4	2/14/2023	205	0.0%	5,092	12/31/2022
2022 Q3	11/14/2022	208	0.0%	6,485	9/30/2022
2022 Q2	8/12/2022	241	0.0%	8,123	6/30/2022
2022 Q1	5/16/2022	214	0.0%	7,609	3/31/2022
2021 Q4	2/14/2022	351	0.0%	7,609	12/31/2021
2021 Q3	11/15/2021	250	0.0%	7,609	9/30/2021
2021 Q2	8/16/2021	267	0.0%	7,609	6/30/2021
2021 Q1	5/14/2021	245	0.0%	6,782	3/31/2021
2020 Q1	5/15/2020	234	0.0%	5,746	3/31/2020
2019 Q4	2/14/2020	371	0.0%	6,013	12/31/2019